Results from VERIFY, An International, Randomized Phase 3 Double-blind Placebo-controlled Study of Rusfertide (First-In-Class Hepcidin Mimetic) for Treatment of Polycythemia Vera (PV) Pemmaraju N, et al
Society of Hematologic Oncology (SOHO) 2025 Annual Meeting
calendar_today
September 3, 2025
domain
protagonist-therapeutics